Product Images Dianeal Pd-2 With Dextrose

This document provides prescribing information regarding the temporary importation of DIANEAL PD-2 Peritoneal Dialysis Solution with 1.5% Dextrose from Guangzhou, China to address drug shortages in the United States. It outlines details about the product, the manufacturing facility, authorization, distribution restrictions, and the necessary approvals from the FDA. Healthcare professionals are advised to review all provided letters for comprehensive information and adhere to the specified guidelines during the designated importation period.*

This is product information related to DIANEAL PD-2 solution used for peritoneal dialysis. The text explains differences between the U.S.-manufactured and China-manufactured versions, including packaging details, container labeling, and barcode usage. It also provides guidance on adjustment in prescription, usage, and administration due to these differences, emphasizing safety and accuracy in using the correct product. Additionally, it includes instructions on reporting adverse events and quality issues, along with contact information for Baxter and the FDA. Healthcare providers are encouraged to refer to the FDA-approved prescribing information for comprehensive details.*

This is a communication from Baxter Healthcare Corporation regarding the use of imported DIANEAL PD-2 with 15% Dextrose (2000 mL). For any questions or placing orders, contact Baxter's Medical Information Service at 1-838-736-2543 or Baxter's Center for Home Care Services at 1-800-284-4060. The communication is signed by Geovana Basso, MD, Director of Americas Medical Affairs. The document also mentions the registered trademarks of Baxter and Dianeal. An attachment regarding Product Comparison Tables 1and 2 is included.*

This text provides detailed information on DIANEAL Peritoneal Dialysis Solutions for APD therapy, comparing various products in terms of composition, volume, containers used, indications, and electrolyte contents. It also includes data on glucose concentration, sodium, calcium, magnesium, chloride, lactate, and osmolarity levels among the different solutions offered. This comparison can be valuable for healthcare professionals and patients involved in peritoneal dialysis treatment decision-making.*

This text is describing a Baxter product that includes DIANEAL Low Calcium PD2 solution with 15% Dextrose, approved by the U.S. FDA. The storage conditions recommend keeping the product at room temperature and brief exposure to temperatures up to 40°C. The expiration date varies depending on the volume of the solution. The product comes in different container types with color-coded pulling caps for easy identification. It provides specific details about glucose concentrations within the solution.*

This is a description for a Peritoneal Dialysis Solution by Baxter called Dianeal® PD-2. It contains 1.5% Dextrose and various electrolytes like Sodium Chloride, Calcium Chloride, and Magnesium Chloride. The solution is intended for intraperitoneal administration only and should be used under the direction of a physician. The package insert should be read for full information. The solution should be stored in a moisture barrier at room temperature. The manufacturer is Baxter Healthcare (Guangzhou) Co Ltd in Guangzhou, China, and the solution is contained in a plastic Ambu-Flex™ II container.*